Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial

Abstract

Autologous iNKT cell treatment is safe and well-tolerated. Expanded iNKT cells produce Th1-like responses with possible antitumor activity. The antitumor effects of iNKT cell infusion in patients with advanced HCC merit further investigation.

References

Page 1

	Year	Citations
Transection of the oesophagus for bleeding oesophageal varices R. N. H. Pugh, I M Murray-Lyon, J L Dawson, British journal of surgery VaricesEsophagusHepatologyEmergency LigationPatient Safety	1973	7.9K
CD1d-Restricted and TCR-Mediated Activation of V <sub>α</sub> 14 NKT Cells by Glycosylceramides Tetsu Kawano, Junqing Cui, Yasuhiko Koezuka, Science Adaptive Immune SystemImmune RegulationImmunologyNk CellsImmunologic Mechanism	1997	2.4K
An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. Olivier Lantz, Albert Bendelac The Journal of Experimental Medicine Autoimmune DiseaseCd4-8- T CellsT-regulatory CellUnique SubsetImmunology	1994	1K
Central memory self/tumor-reactive CD8 <sup>+</sup> T cells confer superior antitumor immunity compared with effector memory T cells Christopher A. Klebanoff, Luca Gattinoni, Parizad Torabi‐Parizi, Proceedings of the National Academy of Sciences	2005	950
Cutting Edge: Cross-Talk Between Cells of the Innate Immune System: NKT Cells Rapidly Activate NK Cells Claude Carnaud, Daniel Lee, Olivier Donnars, The Journal of Immunology Adaptive Immune SystemInnate Immune SystemImmunologyNk CellsImmunologic Mechanism	1999	851
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells Mark J. Smyth, Kevin Thia, Shayna E.A. Street, The Journal of Experimental Medicine ImmunologyNk CellsPathologyImmunologic MechanismImmunotherapy	2000	802
Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer Staining Jenny E. Gumperz, Sachiko Miyake, Takashi Yamamura, The Journal of Experimental Medicine	2002	761
CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor Natalie A. Borg, K.S. Wun, Lars Kjer‐Nielsen, Nature ImmunologyAntigen ProcessingT Cell ImmunityCd4 T Cell ResponsesCd1d–lipid-antigen Recognition	2007	572
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells Tetsu Kawano, Junqing Cui, Yasuhiko Koezuka, Proceedings of the National Academy of Sciences Cancer ImmunosurveillanceImmunologyTumor ImmunityCell DeathValpha14 Nkt Cells	1998	476
CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells Franca Spada, Yasuhiko Koezuka, Steven A. Porcelli The Journal of Experimental Medicine	1998	440

Page 1